Lilian Tengborn (Former)
1 – 15 of 28
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Hemostas
2016)(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Tranexamic acid - an old drug still going strong and making a revival.
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
(
- Contribution to journal › Article
-
Mark
Demographic and clinical data in acquired hemophilia a: results from the european acquired haemophilia (each2) registry.
(
- Contribution to journal › Article
-
Mark
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.
(
- Contribution to journal › Article
-
Mark
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Article
- 2010
-
Mark
Inhibitor Eradication In Acquired Haemophilia A Final Results of European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Published meeting abstract
-
Mark
Acquired Haemophilia Clinical and Demographic Data Results of European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Published meeting abstract
-
Mark
Management of Bleeding In Acquired Hemophilia Results of the European Acquired Hemophilia Registry (EACH2)
(
- Contribution to journal › Published meeting abstract
-
Mark
Acquired Haemophilia A and Pregnancy/Postpartum - a Report From a European Registry
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Trombocytopeni kan vara HIT. Heparinbehandling kan ge livshotande låga trombocytvärden
(
- Contribution to journal › Article
- 2007
-
Mark
Lack of very strong association between pre-treatment fibrinogen and PAI-1 with long-term mortality after coronary bypass surgery
(
- Contribution to journal › Article
- 2004
-
Mark
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
(
- Contribution to journal › Article
- 2003
-
Mark
Experience with a new percutaneous port system, Percuseal(R), for intravenous injection in patients with haemophilia, von Willebrand disease and severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
(
- Contribution to journal › Article